NCT07171983
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
BMY — BRISTOL MYERS SQUIBB CO
Phase 1
• Rheumatoid Arthritis
TL;DR
Locations updated — PHASE1
What changed
Recent events (last 90 days)
What to check next
- Review CT.gov update history and company disclosures for context.
- Verify whether registry updates lag press releases.